Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 243-019-1 | CAS number: 19395-39-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
- Endpoint:
- carcinogenicity
- Type of information:
- (Q)SAR
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
- QSAR prediction: migrated from IUCLID 5.6
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 2015
Materials and methods
- Principles of method if other than guideline:
- Carcinogenicity on rat (male, female and composite) was estimated by using two predictors: Leadscope Model Applier and ACD/Percepta
- GLP compliance:
- no
Test material
- Reference substance name:
- α-phenylpiperidine-2-acetamide
- EC Number:
- 243-019-1
- EC Name:
- α-phenylpiperidine-2-acetamide
- Cas Number:
- 19395-39-2
- Molecular formula:
- C13H18N2O
- IUPAC Name:
- 2-phenyl-2-(piperidin-2-yl)acetamide
Constituent 1
Test animals
- Species:
- rat
- Sex:
- male/female
Results and discussion
Effect levels
- Dose descriptor:
- other: alert
- Sex:
- male/female
- Basis for effect level:
- other: Negative prediction, little reliable
- Remarks on result:
- other: Effect type: carcinogenicity (migrated information)
Any other information on results incl. tables
The prediction results are illustrated in Table:
Model | Leadscope | ACD/Percepta | Consensus |
Rat male | NEGATIVELittle reliable | - | NEGATIVELittle reliable |
Rat female | NEGATIVELittle reliable | - | NEGATIVELittle reliable |
Rat composite | NEGATIVELittle reliable | UNDEFINEDBorderline reliable | NEGATIVELittle reliable |
Leadscope Model Applier
The table shows the result of Leadscope model which includes a prediction (positive, negative or not in domain), a positive prediction probability and two parameters which assess the reliability of the prediction.
Model | LeadscopePredictioncall | LeadscopePositivePrediction probability | Model FeaturesCount | 30% Sim. Training Neighbors Count | Reliabilityassessment |
Rat male | NEGATIVE | 0.41 | 18 | 2 | LITTLE RELIABLE |
Rat female | NEGATIVE | 0.13 | 20 | 2 | LITTLE RELIABLE |
Rat composite | NEGATIVE | 0.14 | 19 | 2 | LITTLE RELIABLE |
Model Features Count. Parameter used to verify that the target compound, i.e.2-phenyl-2-piperidin-2-ylacetamide, contains a significant number of features that are present in the prediction model. The structural features used to make the prediction provide information on the reliability of the prediction: a prediction provided by a low number of features means that the model is not able to fully describe the test compound, while a prediction supported by a high number of features reveals that the test compound is well described by the model. Since 18, 20 and 19 features were found for carcinogenicity on rat male, female and composite, respectively, it was concluded that 2-phenyl-2-piperidin-2-ylacetamide is well represented by the models.
30% Similarity Training Neighbours Count. Number of compounds structurally similar to the target, i.e. 2-phenyl-2-piperidin-2-ylacetamide, in the model's training set of compounds. Another way to assess the reliability of the prediction is looking at the analogues, i.e. the compounds structurally similar to the target in the model's training set of compounds. While this information does not take part to the prediction, it provides the user a complementary means to see how similar compounds were predicted and what the experimental values of similar compounds are. Look at analogues is also an initial, less-sophisticated easy way to understand estimate of toxicity. Two compounds (in common in the rat male, female and composite models) were identified in the training set as analogues to 2-phenyl-2-piperidin-2-ylacetamide, illustrated in the Table. It has to be noted that the identified analogues exhibit little similarity with respect to the target 2-phenyl-2-piperidin-2-ylacetamide, and inconsistent experimental data, being Methylphenidate negative while Atenolol is positive. Therefore, the predictions were considered of little reliability.
Methylphenidate Result: NEGATIVESimilarity: 0.58 |
Atenolol Result: POSITIVE Similarity: 0.32 |
ACD/Percepta
The ACD/Perceptacarcinogenicity on rat predictions reliability is estimated with the reliability index (RI), whichtakes into account the similarity of the tested compound with the training set compounds and the consistency of experimental values for similar compounds. Itranges from0 to 1: if the RI is less than 0.3 the prediction has to be considered not reliable while if RI is more than 0.5 the prediction is considered reliable.
ACD/Percepta did not provide any prediction of carcinogenicity on rat male and female since the target substance resulted to be out of the models domain. ACD/Percepta prediction of carcinogenicity on rat compositeresulted to be undefined, meaning that it cannot be can be reliably classified on the basis of the positive probability (0.26) and the reliability index value (0.39).
Together with the prediction, ACD/Percepta displays up to 5 most structurally similar structures from the training set along with their experimental test results for the corresponding compounds. The structural similarity is evaluated by a fragmental approach. The information on the structurally similar compounds in the training set is used to further assess the reliability of the prediction, since it illustrates how the test compound, i.e. 2-phenyl-2-piperidin-2-ylacetamide, is represented in the training set. The five mostly similar compounds from the training set of the carcinogenicity onrat composite, illustrated in the Table, exhibit moderate similarity with respect to 2-phenyl-2-piperidin-2-ylacetamide meaning that the target compound is moderately represented in the training set of the model. It has also to be noted that the five training set chemicals mostly similar toc-racemateexhibit consistent experimental test results, being all of them negative. Thus, taking into account the little positive probability value and the negative experimental test results of the training chemicals mostly similar to the target, it was concluded that 2-phenyl-2-piperidin-2-ylacetamide is likely to be negative for carcinogenicity on ratcomposite.
METHYLPHENIDATE Result: negative Similarity: 0.64 |
FROVATRIPTAN Result: negative Similarity: 0.59 |
CAPROLACTAM Result: negative Similarity: 0.58 |
PHENFORMINR esult: negative Similarity: 0.57 |
DISOPYRAMIDE Result: negativeSimilarity: 0.57 |
Applicant's summary and conclusion
- Conclusions:
- Carcinogenicity on rat male, female and composite of the target was estimated by using two predictors: Leadscope Model Applier and ACD/Percepta. The two predictors were employed in order to apply a consensus approach to enhance the reliability of the prediction. In the consensus assessment only reliable predictions are to be taken into account. Concerning carcinogenicity on rat male and female, based on Leadscope predictions it was concluded that the target 2-phenyl-2-piperidin-2-ylacetamide is NEGATIVE, although the predictions were assessed as little reliable. Concerning carcinogenicity on rat composite, based on both ACD/Percepta and Leadscope predictions it was concluded that the target 2-phenyl-2-piperidin-2-ylacetamide is NEGATIVE, although the prediction was assessed as little reliable.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.